Recent research suggests that protective antibodies from Covid-19 vaccines, specifically the mRNA type, tend to decline ...

Discover groundbreaking research from Emory University that has revealed that autoantibodies found in the nasal cavity may ...

From sending cancer into remission to alleviating COVID-19 symptoms, immunotherapy can provide revolutionary disease treatments. Immunotherapies use antibodies—proteins that bind to cell markers ...

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...

COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

Repeated mRNA vaccinations boost mucosal antibodies, improving defense against COVID-19. This may help enhance protection ...

Medicare Part B covers molecular, antigen, and antibody coronavirus testing from Medicare-approved labs. Medicare does not cover over-the-counter home test kits. Various tests can detect COVID-19 ...

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

Since early in the pandemic, their work has helped researchers and officials understand the impact of COVID-19 on Canadians ...